Evidence map›Paper›PMID 40990041›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Mitochondria-Localized Nestin Protects Mesenchymal Stem Cells from Senescence by Maintaining Cristae Structure and Function.

Hainan Chen, Jinsi Chen, Li Huang, Xingqiang Lai, Kai Xia, Qiying Lu, Bingbing Xie, Yinong Huang, Yuan Qiu, Tao Wang and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Engineered NestinJournal of extracellular vesicles · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hainan ChenStem Cells and Regenerative Medicine Joint Laboratory of Sun Yat-sen University and Gaozhou People's Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Jinsi ChenStem Cells and Regenerative Medicine Joint Laboratory of Sun Yat-sen University and Gaozhou People's Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Li HuangStem Cells and Regenerative Medicine Joint Laboratory of Sun Yat-sen University and Gaozhou People's Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Xingqiang LaiMaternal-Fetal Medicine Institute, Department of Obstetrics and Gynaecology, Shenzhen Baoan Women's and Children's Hospital, Shenzhen, 518033, China.
Kai XiaStem Cells and Regenerative Medicine Joint Laboratory of Sun Yat-sen University and Gaozhou People's Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Qiying LuDepartment of Rehabilitation Medicine, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Bingbing XieKey Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou, 510080, China.
Yinong HuangDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, China.
Yuan QiuKey Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-Sen University, Guangzhou, 510080, China.
Tao WangStem Cells and Regenerative Medicine Joint Laboratory of Sun Yat-sen University and Gaozhou People's Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Jianqi FengCenter for Stem Cells Translational Medicine, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, 518107, China.
Yuanjun GuanCore Facilities Center for Medical Science, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, China.
Siyao CheStem Cells and Regenerative Medicine Joint Laboratory of Sun Yat-sen University and Gaozhou People's Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Jiancheng WangScientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, 518107, China.
Andy Peng XiangStem Cells and Regenerative Medicine Joint Laboratory of Sun Yat-sen University and Gaozhou People's Hospital, Sun Yat-sen University, Guangzhou, 510080, China.ORCID https://orcid.org/0000-0003-3409-5012

Funding

Key Technologies Research and Development Program 2022YFA1104100Key Technologies Research and Development Program of Guangzhou Municipality 2023B01J1002Medical Science and Technology Research Fund of Guangdong Province B2025182National Natural Science Foundation of China 32130046National Natural Science Foundation of China 32170799National Natural Science Foundation of China 82371608National Natural Science Foundation of China 82371611National Natural Science Foundation of China 82430050National Natural Science Foundation of China 82500348Natural Science Foundation of Guangdong Province 2022A1515010371Sanming Project of Medicine in Shenzen Municipality SZSM202103012Science and Technology Planning Project of Gaozhou 2023SZX028
6 · The paper itself

Abstract

Nestin, a well-characterized intermediate filament protein expressed in stem cells, is increasingly recognized for its non-canonical roles in diverse subcellular compartments. Here, a novel mitochondrial localization of Nestin in human mesenchymal stem cells (hMSCs) is identified, where it functions as a critical protector against mitochondrial dysfunction and cellular senescence. It is demonstrated that Nestin is imported into the mitochondrial intermembrane space via its N-terminal mitochondrial targeting sequence through Translocase of the Outer Mitochondrial Membrane 20 (TOM20)-dependent machinery. Within mitochondria, Nestin directly interacts with Mic60 to maintain cristae architecture and sustain oxidative phosphorylation. Genetic ablation of mitochondrial Nestin triggers cristae disorganization, respiratory deficiency, and premature senescence in hMSCs. Strikingly, targeted restoration of the Mic60-binding Tail3 domain of Nestin is sufficient to rescue cristae morphology, mitochondrial function, and senescence phenotypes. These findings establish a non-filamentous role for Nestin in mitochondrial quality control and propose a new therapeutic strategy for age-related disorders through modulation of mitochondrial Nestin-Mic60 interactions.

Indexed as

Cellular SenescenceMesenchymal Stem CellsMitochondriaNestinCells, CulturedHumansNES protein, humanNestinCellular senescencehuman mesenchymal stem cells (hMSCs)Mic60MitochondriaNestin

Identifiers

PMID40990041
PMCPMC12697773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.